Every SEC Form 3/4/5 on record for this filer (CIK 1181561) — 1 issuer, 22 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| JNJ | JOHNSON & JOHNSON | EVP, Innovative Medicine, R&D | 2023-04-13 → 2026-05-04 | 12 | −$20M |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| JNJ | 2026-02-17 | Sell | 21,721 | $243.00 | $5M | 12,941 |
| JNJ | 2026-02-17 | Sell | 2,283 | $243.00 | $554,769 | 10,658 |
| JNJ | 2026-02-17 | Sell | 29,927 | $243.00 | $7M | 12,941 |
1 of 1 issuers are covered and open a security page; the rest are on file here only.